Glutamate Metabotropic Receptor 4 (GRM4) Antibody

Este producto es parte de GRM - Glutamate Receptor Metabotropic
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Glutamate Metabotropic Receptor 4 (GRM4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx328351
tested applications
ELISA, WB, IHC

Description

GRM4 Antibody is a Rabbit Polyclonal against GRM4.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Glutamate Metabotropic Receptor 4 (GRM4)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
ELISA: 1/10000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q14833
Gene ID
2914
Alias
GRM4,GPRC1D,MGLUR4,mGlu4
Background
Antibody anti-GRM4
Status
RUO

Descripción

GRM4, or mGluR4, belongs to the Group III metabotropic glutamate receptors and primarily couples to Gi/o proteins, inhibiting adenylate cyclase and reducing cyclic AMP (cAMP) levels. GRM4 is predominantly expressed in the cerebellum, basal ganglia, and thalamus, where it functions as a presynaptic receptor to suppress excessive glutamate release. It plays a critical role in regulating synaptic plasticity, motor coordination, and neuronal excitability. GRM4 activation has neuroprotective effects, reducing excitotoxicity and inflammation in neurological conditions. Dysregulation of GRM4 has been associated with Parkinson’s disease, anxiety, and chronic pain, where impaired glutamate signaling contributes to disease pathology. GRM4 agonists are being investigated as therapeutic agents for Parkinson’s disease, as they modulate basal ganglia circuitry and improve motor symptoms. Additionally, GRM4’s role in neuroprotection and reducing inflammation makes it a promising target for treating neurodegenerative diseases, chronic pain, and psychiatric disorders.

Related Products

FNab10032

anti- GRM4 antibody

Ver Producto
abx005491

Glutamate Metabotropic Receptor 4 (GRM4) Antibody

GRM4 Antibody is a Rabbit Polyclonal antibody against GRM4. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Several transcript variants encoding different isoforms have been found for this gene.

Ver Producto
abx011144

Metabotropic Glutamate Receptor 4 (GRM4) Antibody

Metabotropic Glutamate Receptor 4 (GRM4) Antibody is a Rabbit Polyclonal antibody for the detection of GRM4.

Ver Producto